RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Moberg Pharma AB (publ) Stock

Moberg Pharma AB (publ) P/E 2024

Moberg Pharma AB (publ) P/E

-43.48

Ticker

MOB.ST

ISIN

SE0013121340

WKN

A2PUSM

As of Nov 4, 2024, Moberg Pharma AB (publ)'s P/E ratio was -43.48, a 98.72% change from the -21.88 P/E ratio recorded in the previous year.

The Moberg Pharma AB (publ) P/E history

Moberg Pharma AB (publ) Aktienanalyse

What does Moberg Pharma AB (publ) do?

Moberg Pharma AB (Publ) is a Swedish pharmaceutical company that specializes in the development, manufacturing, and marketing of over-the-counter medications and medical products. The company was founded in 2011 and is headquartered in Stockholm, Sweden. It has a strong portfolio of products for pain relief, foot care, and skincare. The company's business model focuses on identifying and tapping into untapped potential in existing markets by developing innovative products that are known for their high quality and effectiveness. Moberg Pharma AB (Publ) has three main divisions: Consumer Health, Specialty Pharma, and Contract Manufacturing. Its Consumer Health division develops and markets over-the-counter health products for consumers, including pain medications, skincare, and foot care products. The Specialty Pharma division focuses on developing medications for the treatment of serious conditions such as dermatological diseases, nail fungus infections, and pain. The Contract Manufacturing division offers a wide range of services for the manufacturing and packaging of pharmaceutical products. Moberg Pharma AB (Publ) is committed to sustainability and social engagement and has launched numerous initiatives to make its practices and products environmentally friendly and sustainable. The company has also established a foundation to support research and innovation in medicine. In summary, Moberg Pharma AB (Publ) is an innovative pharmaceutical company that focuses on the development and marketing of high-quality, effective, over-the-counter medications and medical products. It has a strong product portfolio, a dedicated R&D team, and a proven sales and distribution infrastructure. It is a successful company that is focused on expanding its global presence and tapping into new markets. Moberg Pharma AB (publ) ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/E Details

Deciphering Moberg Pharma AB (publ)'s P/E Ratio

The Price to Earnings (P/E) Ratio of Moberg Pharma AB (publ) is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.

Year-to-Year Comparison

Assessing Moberg Pharma AB (publ)'s P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.

Impact on Investments

The P/E ratio of Moberg Pharma AB (publ) is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.

Interpreting P/E Ratio Fluctuations

Fluctuations in Moberg Pharma AB (publ)’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.

Frequently Asked Questions about Moberg Pharma AB (publ) stock

What is the price-to-earnings ratio of Moberg Pharma AB (publ)?

The price-earnings ratio of Moberg Pharma AB (publ) is currently -43.48.

How has the price-earnings ratio of Moberg Pharma AB (publ) changed compared to last year?

The price-to-earnings ratio of Moberg Pharma AB (publ) has increased by 98.72% increased compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Moberg Pharma AB (publ) high compared to other companies?

Yes, the price-to-earnings ratio of Moberg Pharma AB (publ) is high compared to other companies.

How does an increase in the price-earnings ratio of Moberg Pharma AB (publ) affect the company?

An increase in the price-earnings ratio of Moberg Pharma AB (publ) would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Moberg Pharma AB (publ) affect the company?

A decrease in the price-earnings ratio of Moberg Pharma AB (publ) would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Moberg Pharma AB (publ)?

Some factors that influence the price-earnings ratio of Moberg Pharma AB (publ) are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Moberg Pharma AB (publ) pay?

Over the past 12 months, Moberg Pharma AB (publ) paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Moberg Pharma AB (publ) is expected to pay a dividend of 0 SEK.

What is the dividend yield of Moberg Pharma AB (publ)?

The current dividend yield of Moberg Pharma AB (publ) is .

When does Moberg Pharma AB (publ) pay dividends?

Moberg Pharma AB (publ) pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Moberg Pharma AB (publ)?

Moberg Pharma AB (publ) paid dividends every year for the past 0 years.

What is the dividend of Moberg Pharma AB (publ)?

For the upcoming 12 months, dividends amounting to 0 SEK are expected. This corresponds to a dividend yield of 0 %.

In which sector is Moberg Pharma AB (publ) located?

Moberg Pharma AB (publ) is assigned to the 'Health' sector.

Wann musste ich die Aktien von Moberg Pharma AB (publ) kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Moberg Pharma AB (publ) from 11/4/2024 amounting to 0 SEK, you needed to have the stock in your portfolio before the ex-date on 11/4/2024.

When did Moberg Pharma AB (publ) pay the last dividend?

The last dividend was paid out on 11/4/2024.

What was the dividend of Moberg Pharma AB (publ) in the year 2023?

In the year 2023, Moberg Pharma AB (publ) distributed 0 SEK as dividends.

In which currency does Moberg Pharma AB (publ) pay out the dividend?

The dividends of Moberg Pharma AB (publ) are distributed in SEK.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Moberg Pharma AB (publ)

Our stock analysis for Moberg Pharma AB (publ) Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Moberg Pharma AB (publ) Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.